How much revenue did Il Dong Pharmaceutical Co generate this year?
Il Dong Pharmaceutical Co has achieved a revenue of 660.64 B KRW this year.
In 2024, Il Dong Pharmaceutical Co's sales reached 660.64 B KRW, a 9.97% difference from the 600.76 B KRW sales recorded in the previous year.
YEAR | REVENUE (undefined KRW) | GROSS MARGIN (%) |
---|---|---|
2026e | 765.58 | 27,93 |
2025e | 718.11 | 29,78 |
2024e | 660.64 | 32,37 |
2023 | 600.76 | 35,60 |
2022 | 637.71 | 37,06 |
2021 | 560.13 | 39,18 |
2020 | 561.85 | 42,43 |
2019 | 517.47 | 44,90 |
2018 | 503.91 | 50,64 |
2017 | 460.65 | 49,11 |
2016 | 201.34 | 48,32 |
The sales figures of Il Dong Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Analyzing Il Dong Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Investors often scrutinize Il Dong Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Increases in Il Dong Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Il Dong Pharmaceutical Co has achieved a revenue of 660.64 B KRW this year.
The revenue of Il Dong Pharmaceutical Co has increased by 9.97% increased compared to the previous year.
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
The revenue of Il Dong Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
The revenue of Il Dong Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
Over the past 12 months, Il Dong Pharmaceutical Co paid a dividend of 362.81 KRW . This corresponds to a dividend yield of about 2.62 %. For the coming 12 months, Il Dong Pharmaceutical Co is expected to pay a dividend of 0 KRW.
The current dividend yield of Il Dong Pharmaceutical Co is 2.62 %.
Il Dong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .
Il Dong Pharmaceutical Co paid dividends every year for the past 3 years.
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
Il Dong Pharmaceutical Co is assigned to the 'Health' sector.
To receive the latest dividend of Il Dong Pharmaceutical Co from 4/11/2019 amounting to 380.952 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2018.
The last dividend was paid out on 4/11/2019.
In the year 2023, Il Dong Pharmaceutical Co distributed 0 KRW as dividends.
The dividends of Il Dong Pharmaceutical Co are distributed in KRW.
Our stock analysis for Il Dong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Il Dong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.